Palomino Laboratories Inc.
PALX- Exchange
- OTC
- Industry
- Semiconductors & Related Devices
- SEC CIK
- 0001938569
No open-market purchases or sales by Palomino Laboratories Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PALX, Q2 2026
No superinvestor reported holding PALX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Palomino Laboratories Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 20 | Same day | Ogawa RichardSecretary | PPurchase | +12.5K | $4.00 | +$50.0K | +0.7%1.76M after | |
| Apr 20, 2026 (view filing) | Apr 20 | Same day | Denbaars StevenDirector | PPurchase | +12.5K | $4.00 | +$50.0K | +0.7%1.76M after | |
| Oct 27, 2025 (view filing) | Sep 29 | 28 daysLate | Shealy Jeffrey B.President and CEO | SSale | +833.3K | $1.20 | +$1.00M | –4.67M after | Derivative |
| Oct 9, 2025 (view filing) | Sep 29 | 10 daysLate | Denbaars StevenDirector | SSale | +125.0K | $1.20 | +$150.0K | –125.0K after | Derivative |
| Oct 9, 2025 (view filing) | Sep 29 | 10 daysLate | Ogawa RichardSecretary | SSale | +125.0K | $1.20 | +$150.0K | –125.0K after | Derivative |
| Oct 9, 2025 (view filing) | Sep 29 | 10 daysLate | Tu JasonChief Accounting Officer | SSale | +41.7K | $1.20 | +$50.0K | –41.7K after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in Palomino Laboratories Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding PALX in 13F filings for Q2 2026.